TECHWIRE 30
(CIX: WRAL30)  986.18    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: Apple)  524.94    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: QUINTILES)  50.22    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(OP: BASF SE)  110.32    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: BioCryst)  8.34    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: BioDelivery)  7.42    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: CEMP)  9.67    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: Cisco Systems)  23.21    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: Cornerstone)  9.49    (0 %)  Updated: 08:10 PM EST, Feb 03 2014
(NQ: Cree)  56.54    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: DARA)  2.55    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: EMC CORPORATION)  26.62    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(NQ: Extreme Networks)  5.67    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: Facebook)  58.94    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: GLAXOSMITHKLINE)  52.51    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(NQ: GOOG)  536.10    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: IBM)  190.01    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(NY: LH)  101.31    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(OP: Lenovo Group)  23.91    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: MRK)  56.47    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(NQ: Microsoft Corp)  40.01    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: NetApp)  35.87    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: NOVARTIS AG)  84.67    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(OP: Novozymes A/S)  44.76    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: PFIZER)  30.25    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(NQ: Pozen)  8.70    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NY: RED HAT)  50.55    (0 %)  Updated: 06:40 PM EDT, Apr 17 2014
(NQ: BBRY)  7.15    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: Salix)  101.06    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014
(NQ: SQI)  26.05    (0 %)  Updated: 08:10 PM EDT, Apr 17 2014

Posts tagged “Salix”

August 25, 2005

Premium Lock Drug Manufacturer Salix Suggests Better Treatment for Relief of Cancer Side Effects

Study suggests relief is in site for patients receiving medical treatment for prostate cancer. Drug may have a new purpose.

Tags: Salix
August 9, 2005

Premium Lock Earnings: Salix Reports Surge in Profits; Inspire Revenues Climb

Salix produces 13-cent a share profit as sales far outpace expenses; Inspire cuts losses as co-marketed drug sales increase; Icagen reports a loss but notes progress on drugs.

August 27, 2004

Premium Lock TriVirix Sets Pace for 2004 North Carolina 'Top 50' Tech Firms

Deloitte says leading technology firms increase revenues by 599 percent over five years. TriVirix revenues soar 8881 percent.'Rising Stars' include PowerByHand, LVL7.

August 9, 2004

Premium Lock Soaring Drug Sales, New Product Have Salix Talking About Profitability

Pharmaceutical firm says Colazal revenue climbs 46 percent, beats analyst expectations. New drug now hitting market. CFO sees $100 million in revenue this year.

Tags: Salix
February 3, 2004

Premium Lock Salix Posts Positive Q4 Results, Expects Profit as Stock Climbs

<b>Updated:</b> Narrows net loss and grows revenue, on 53 percent increase in Colazal sales. Continued growth will lead to profitability in 2004, Salix says, as stock jumps 17 percent.

Tags: Salix
Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll